Yahoo Web Search

Search results

    • Pfizer Scoops Up Sickle Disease Player For $5B

      Pfizer Scoops Up Sickle Disease Player For $5B

      Benzinga via Yahoo Finance· 2 years ago

      Pfizer Inc (NYSE: PFE) has agreed to acquire Global Blood Therapeutics Inc (NASDAQ: GBT) for $68.50 per share in cash, for a total enterprise value of...